The biological sense of cancer: A hypothesis

Theoretical Biology and Medical Modelling

Volumn 3, Issue , 2006, Pages

  Ruggiero, Raúl A ^a   Bustuoabad, Oscar D ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; AGING; ARTICLE; CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER THERAPY; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL AGING; CELL DAMAGE; CELL DEATH; CELL DISRUPTION; CELL FUNCTION; CELL GROWTH; CELL KILLING; CELL PROLIFERATION; DEVELOPMENTAL STAGE; EMBRYO DEVELOPMENT; ENVIRONMENTAL FACTOR; HYPOTHESIS; IN VITRO STUDY; METASTASIS; MOLECULAR BIOLOGY; MULTIPLE ORGAN FAILURE; NONHUMAN; ORGAN INJURY; PHYSIOLOGY; PLANT TUMOR; SIGNAL TRANSDUCTION; TISSUE INJURY; TISSUE REGENERATION; TOPOGRAPHY; TUMOR CELL; TUMOR GROWTH; CELL DIFFERENTIATION; HUMAN; NEOPLASMS; PATHOPHYSIOLOGY;

ANIMALIA;

ADAPTATION, PHYSIOLOGICAL; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYONIC DEVELOPMENT; HUMANS; NEOPLASMS;

EID: 33846921326     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-3-43     Document Type: Article

References (97)

1. Capasso LL: Antiquity of cancer. Int J Cancer 2005, 113:2-13.
2. Rothschild BM, Witzke BJ, Hershkovitz I: Metastatic cancer in the Jurassic. Lancet 1999, 354:398.
3. Czarnetzki A, Schwaderer E, Pusch CM: Fossil record of meningioma. Lancet 2003, 362:408.
4. Shimkin MB: Contrary to Nature Washington: Public Health Service, National Institute of Health; 1977.
5. Bishop JM: The molecular biology of RNA tumor viruses: a physician's guide. Basic science for clinicians. N Engl J Med 1980, 303:675-682.
6. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100:57-70.
7. Bignold LP: The mutator phenotype theory can explain the complex morphology and behavior of cancer. Cell Mol Life Sci 2002, 59:950-958.
8. Frank SA: Age-specific incidence of inherited versus sporadic cancers: a test for the multistage theory of carcinogenesis. Proc Natl Acad Sci USA 2005, 102:1071-1075.
9. Duesberg P, Rasnick D: Aneuplody, the somatic mutation that makes cancer a species of its own. Cell Motil Cytoskel 2000, 47:81-107.
10. Sonnenschein C, Soto AM: Somatic mutation theory of carcinogenesis: why it should be dropped and replaced. Mol Carcinogenesis 2000, 29:205-211.
11. Prehn RT: The role of mutation in the new cancer paradigm. Cancer Cell Int 2005, 5:9-14.
12. Bailar JC III, Gornik HL: Cancer undefeated. N Engl J Med 1997, 336:1569-1574.
13. Prehn RT: Regeneration versus neoplastic growth. Carcinogenesis 1997, 18:1439-1444.
14. Zajicek G: A new cancer hypothesis. Med Hypoth 1996, 47:111-115.
15. Kenny PA, Bissell MJ: Tumor reversion: correction of malignant behavior by microenvironmental cues. Int J Cancer 2003, 107:688-695.
16. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C: The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 2004, 117:1495-1502.
17. Walker CW, Boom JDG, Marsh AG: First non-vertebrate member of the myc gene family is seasonally expressed in an invertebrate testis. Oncogene 1992, 7:2007-2012.
18. Wellings SR: Neoplasia and primitive vertebrate phylogeny: echinoderms, prevertebrates and fishes. A review. Natl Cancer Inst Monograph 1969, 31:59-128.
19. Sparks AK: Review of tumors and tumor-like conditions in Protozoa, Coelenterata, Platyhelminthes, Annelida, Sipunculida and Arthropoda excluding Insects. Natl Cancer Inst Monograph 1969, 31:671-682.
20. Dawe CJ: Phylogeny and oncogeny. Natl Cancer Inst Monograph 1969, 31:1-40.
21. Hall F, Morita M, Best JB: Neoplastic transformation in the planarian: Cocarcinogenesis and histopathology. J Exp Zool 1986, 240:211-227.
22. Del Rio-Tsonis K, Tsonis PA: Amphibian tissue regeneration: a model for cancer regulation (review). Int J Oncol 1992, 1:161-164.
23. Mechler BM, Strand D, Kalmes A, Merz R, Schmidt M, Torok I: Drosophila as a model system for molecular analysis of tumorigenesis. Environ Health Perspect 1991, 93:63-71.
24. Taylor RL: Formation of tumor-like lesions in the cockroach Leucophaea maderae after decapitation. Natl Cancer Inst Monograph 1969, 31:419-432.
25. Lopez A: Tumoral pathology in spiders. J Invertebr Pathol 1979, 34:224-230.
26. Caussinus E, Gonzalez C: Induction of tumor growth by altered stem-cell asymmetric división in Drosophila melanogaster. Nature Genet 2005, 37:1027-1028.
27. Zilakos NP, Tsonis PA, Del Rio-Tsonis K, Parchment RE: Newt squamous carcinoma proves phylogenetic conservation of tumors as caricatures of tissue renewal. Cancer Res 1992, 52:4858-4865.
28. Okanoto M: Simultaneous demonstration of lens regeneration from dorsal iris and tumor production from ventral iris in the same newt eye after carcinogen administration. Differentiation 1997, 61:285-292.
29. th annual meeting of the Japanese society for biomedical gerontology. Tokyo Cancer Immunol Immunother 2005, 54:623-634.
30. Karin M, Lawrence T, Nizet V: Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006, 124:823-836.
31. Harrison SA, Bacon BR: Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment and prevention. Med Clin North Am 2005, 89:391-409.
32. Zamaraev VN: Does regenerative capacity decrease with age? Sov J Dev Biol 1974, 4:495-503.
33. Sharpless NE, DePinho RA: Telomeres, stem cells, senescence and cancer. J Clin Invest 2004, 113:160-168.
34. Haddow A: Cellular inhibition and the origin of cancer. Acta Unio Int Contra Cancrum 1938, 3:342-352.
35. Farber E, Rubin H: Cellular adaptation in the origin and development of cancer. Cancer Res 1991, 51:2751-2761.
36. Farber E: Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res 1995, 55:3759-3762.
37. Simpson CJ, Bissell MJ, Werb Z: Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1. Semin Cancer Biol 1995, 6:159-163.
38. Dvorak HF: Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986, 315:1650-1691.
39. Hoel DG, Haseman JK, Hogan MD, Huff J, Mc Connell E: The impact of toxicity on carcinogeneity studies: implications for risk assessment. Carcinogenesis 1988, 9:2043-2052.
40. Asare GA, Paterson AC, Kero MC, Khan S, Mossanda KS: Iron-free neoplastic nodules and hepatocellular carcinoma without cirrhosis in Wistar rats fed a diet high in iron. J Pathol 2006, 208:82-90.
41. Nery R: Carcinogenic mechanisms: a critical review and a suggestion that oncogenesis may be adaptive ontogenesis. Chem Biol Interact 1976, 12:145-169.
42. Schindel DT, Grosfeld JL: Hepatic resection enhances growth of residual intrahepatic and subcutaneous hepatoma, which is inhibited by octreotide. J Pediatr Surg 1997, 32:995-998.
43. Pliskin ME, Prehn RT: Stimulation of liver regeneration and compensatory kidney hyperplasia by passive transfer of spleen cells. J Reticuloendothel Soc 1975, 17:290-299.
44. Prehn RT: An adaptive immune reaction may be necessary for cancer development. Theor Biol Med Model 2006, 3:6.
45. Sonneschein C, Soto AM: The Society of Cells New York: Springer-Verlag; 1999.
46. Pitot HC: Fundamentals of Oncology New York: Marcel Dekker Inc; 1978.
47. Geneser F: Histología. Buenos Aires: Editorial Médica Panamericana 2000.
48. (translated into Spanish from Histologi Copenhagen: Munksgaard; 1999)
49. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS: Loss of heterozygosity in normal tissue adjacent to breast carcinoma. Science 1996, 274:2057-2059.
50. Mirsalis JC, Shimon JA, Johnson A, Fairchild D, Kanazawa N, Nguyen T, de Boer J, Glickman B, Winegar RA: Evaluation of mutant frequencies of chemically induced tumors and normal tissues in I/c II transgenic mice. Environ Mol Mutagen 2005, 45:17-35.
51. Lengauer C, Kinzler KW, Vogelstein B: Genetic instabilities in human cancers. Nature 1998, 396:643-649.
52. Suss R, Kinzel V, Scribner JD: Cancer. Experiments and Concepts New York, Heidelberg, Berlin: Springer-Verlag; 1973.
53. Cotran RS, Kumar V, Collins T, (editors): Tissue repair: cellular growth, fibrosis and wound healing. In Robbins Pathologic basis of disease 6th edition. New York: WB Saunders; 1999:89-112.
54. Ewing J: Neoplastic Disease: a Treatise on Tumors Philadelphia: Saunders; 1940.
55. Hahn WC, Weinberg RA: Modelling the molecular circuitry of cancer. Nature Rev Cancer 2002, 2:331-341.
56. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993, 363:558-561.
57. Jaffe LF: Epigenetic theories of cancer initiation. Adv Cancer Res 2004, 90:209-230.
58. Sato M, Vaughan MB, Girard L, Peyton M, Lee W, Shames DS, Ramirez RD, Sunaga N, Gazdar AF, Shay JW, Minna JD: Multiple oncogenic changes (K-RAS (v 12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 2006, 66:2116-2128.
59. Brand KG: Cancer associated with asbestosis, schistosomiasis, foreign bodies and scars. In Cancer: A Comprehensive Treatise Edited by: Becker FF. New York: Plenum Press; 1982:661-692.
60. Pasqualini CD, Ruggiero RA, Bustuoabad OD, Nepomnaschy I, Piazzon I: Experimental onco-immunology revisited. Curr Cancer Therapy Rev 2005, 1:289-298.
61. Furth J: Conditioned and autonomous neoplasms: a review. Cancer Res 1953, 13:477-492.
62. Andervont HB, Dunn TB: Occurrence of tumors in wild house mice. J Natl Cancer Inst 1962, 28:1153-1163.
63. Hahn WC, Weinberg RA: Rules for making human tumor cells. N Engl J Med 2002, 347:1593-1603.
64. Rudo K, Meyers WC, Dauterman W, Langenbach R: Comparison of human and rat hepatocyte metabolism and mutagenic activation of 2-acetylaminofluorene. Cancer Res 1987, 47:5861-5867.
65. Hsu IC, Harris CC, Lipsky MM, Snyder S, Trump BF: Cell and species differences in metabolic activation of chemical carcinogens. Mutat Res 1987, 177:1-7.
66. Holliday R: Aging is no longer an unsolved problem in biology. Ann N Y Acad Sci 2006, 1067:1-9.
67. Coussens LM, Fingleton B, Matrisian LM: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002, 295:2387-2392.
68. Tan X, Egami H, Abe M, Nozawa F, Hirota M, Ogawa M: Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway. J Clin Pathol 2005, 58:1242-1248.
69. Elias D, De Baere T, Roche A, Ducreux M, Leclere J, Lasser P: During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 1999, 86:784-788.
70. García Alonso I, Palomares T, Alonso A, Portugal V, Castro B, Carames J, Mendez J: Effect of hepatic resection on development of liver metastases. Rev Esp Enferm Dig 2003, 95:765-770.
71. Li R, Wheeler T, Dai H, Frolov A, Thompson T, Ayala G: High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy. Am J Surg Pathol 2004, 28:928-934.
72. El Saghir NS, Elhajj II, Geara FB, Hourani MH: Trauma-associated growth of suspected micrometastasis. BMC Cancer 2005, 5:94.
73. Glick AB, Yuspa SH: Tissue homeostasis and the control of the neoplastic phenotype in epithelial cancers. Semin Cancer Biol 2005, 15:75-83.
74. Gorelik E: Concomitant tumor immunity and resistance to a second tumor challenge. Adv Cancer Res 1983, 39:71-120.
75. Ruggiero RA, Bustuoabad OD, Cramer P, Bonfil RD, Pasqualini CD: Correlation between seric antitumor activity and concomitant resistance in mice bearing non-immunogenic tumors. Cancer Res 1990, 50:7159-7165.
76. O'Reilly MS, Holmgren L, Sage EH, Folkman J: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994, 79:315-328.
77. Prehn RT: Two competing influences that may explain concomitant tumor resistance. Cancer Res 1993, 53:3266-3269.
78. Shimosato Y, Kameya T, Nagai K, Hirohashi S, Koide T, Hayashi H, Nomura T: Transplantation of human tumors in nude mice. J Natl Cancer Inst 1976, 56:1251-1260.
79. Rubin H: What keeps cells in tissues behaving normally in the face of myriad mutations? BioEssays 2006, 28:515-524.
80. Nathanson SD, Nelson LT, Lee M: A spontaneous subcutaneous tumor in C57BL/6 mice that metastatize to the liver. Clin Exp Metastasis 1993, 11:45-54.
81. Maeda S, Kamata H, Luo JL, Leffert H, Karin M: IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005, 121:977-990.
82. Rosenberg N, Jolicoeur P: Retoviral Pathogenesis. In Retroviruses Edited by: Coffin JM, Hughes SH, Varmus H. New York: Cold Spring Harbor Laboratory Press; 1997:475-585.
83. Adams JM, Cory S: Transgenic models of tumor development. Science 1991, 254:1161-1167.
84. Suzuki A, Itami S, Ohishi M, Hamada K, Inoue T, Komazawa N, Senoo H, Sasaki T, Takeda J, Manabe M, Wah Mak T, Nakano T: Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res 2003, 63:674-681.
85. Pierce GB, Speers WC: Tumors as caricatures of the process of tissue renewal: Prospects for therapy by directing differentiation. Cancer Res 1988, 48:1996-2004.
86. Harris H: A long view of fashions in cancer research. BioEssays 2005, 27:833-838.
87. Formica JV: Crown gall neoplasms. In The Pathobiology of Neoplasia Edited by: Sirica AE. New York: Plenum Press; 1989:497-512.
88. Bayer MH, Kaiser HE, Micozzi MS: Abnormal growth processes in plants and animals: a comparison. In Vivo 1994, 8:3-16.
89. Brencic A, Angert ER, Winans SC: Unwounded plants elicit Agobacterium vir induction and T-DNA transfer: transformed plant cells produce opines yet are tumor free. Mol Microbiol 2005, 57:1522-1531.
90. Zhu J, Oger PM, Schrammeijer B, Houykaas PJJ, Farrand SK, Winans SC: The bases of crown gall tumorigenesis. J Bacteriol 2000, 182:3885-3895.
91. Ullrich CI, Aloni R: Vascularization is a general requirement for growth of plant and animal tumors. J Exp Botany 2000, 51:1951-1960.
92. Galmarini CM, Galmarini FC: Multidrug resistance in cancer therapy: role of the microenvironment. Curr Opin Investig Drugs 2003, 4:1416-1421.
93. Cranmer LD, Trevor KT, Hersh EM: Clinical applications of dendritic cell vaccination in the treatment of cancer. Cancer Immunol Immunother 2004, 53:275-306.
94. Tallman MS, Nabhan C, Feusner JH, Rowe JM: Acute promyelocytic leukemia: evolving therapeutic strategies. Blood 2002, 99:759-767.
95. Schipper H, Turley EA, Braun M: A new biological framework for cancer research. Lancet 1996, 348:1149-1151.
96. Leclerc E, Corlu A, Griscom L, Baudoin R, Legallais C: Guidance of liver and kidney organotypic cultures inside rectangular silicone microchannels. Biomaterials 2006, 27:4109-4119.
97. Bustuoabad OD, Correa JE: Injury and death in the embryo development process: hypothesis of biological self-organization. Frontier Perspectives 2004, 13:34-38.